Fulcher Paul H, Granese Marsha, Chun Yoon, Welch Christine A, Seybold Dara J, Randall Gary, DePond R Todd
W V Med J. 2014 Jan-Feb;110(1):10-5.
Adequately controlling pain is a key component of postoperative care after a hysterectomy. The purpose of this study was to evaluate the effects of two intraperitoneal (IP) administered solutions during Laparoscopic Assisted Vaginal Hysterectomy (LAVH), on the amount of postoperative self-administered morphine. In this prospective, randomized, double blinded study, twenty women undergoing LAVH randomly distributed to two treatment groups: (1) 100 ml dexamethasone/ bupivacaine/ gentamicin (DMG) solution: 60 cc injected vaginally at cuff and 40 cc placed topically via laparoscopy over intra-peritoneal postoperative surfaces (IP) and 5 ml bupivacaine or 5 ml saline injected at the laparoscopic incision sites, (2) 100 ml saline solution: 60 cc injected vaginally at cuff and 40 cc placed topically via laparoscopy over intra-peritoneal postoperative surfaces (IP) and 5 ml bupivacaine or 5 ml saline injected at the laparoscopic incision sites. The amount of morphine utilized by the patients was documented from their patient controlled anesthesia (PCA) pump. Patient parameters recorded included perceived pain score, height, weight, age, race, reason for surgery, pre-surgery medications, American Society of Anesthesiologist (ASA) classification, length of the surgery and estimated blood loss (EBL). Age, EBL, length of surgery, and ASA classification were not significantly different between the groups. The postoperative amount of morphine utilized was higher at 4 (p=.02) and 16 hours (p = .04) and tended to be higher at 8, 12 hours (p=.06), and 24 hours (p=.09) in the saline IP group. Overall the saline IP group (n=10) used (median; range) 21.5; 8-82 mg of morphine while the DMG IP group (n=10) used 10.5; 1-23 mg. No participants reported a postoperative infection. This study demonstrates that intraoperative utilization of DMG solution during LAVH enables patients clinically to have less perceived pain and subsequently tend to utilize about half the amount of morphine, helping to avoid the potential harmful side effects and adverse reactions of morphine.
充分控制疼痛是子宫切除术后护理的关键组成部分。本研究的目的是评估在腹腔镜辅助阴式子宫切除术(LAVH)期间两种腹腔内(IP)给药溶液对术后患者自控吗啡用量的影响。在这项前瞻性、随机、双盲研究中,20例行LAVH的女性被随机分为两个治疗组:(1)100毫升地塞米松/布比卡因/庆大霉素(DMG)溶液:60毫升经阴道注入残端,40毫升通过腹腔镜局部置于腹腔术后表面(IP),并在腹腔镜切口部位注入5毫升布比卡因或5毫升生理盐水;(2)100毫升生理盐水溶液:60毫升经阴道注入残端,40毫升通过腹腔镜局部置于腹腔术后表面(IP),并在腹腔镜切口部位注入5毫升布比卡因或5毫升生理盐水。记录患者从患者自控镇痛(PCA)泵使用的吗啡量。记录的患者参数包括疼痛感知评分、身高、体重、年龄、种族、手术原因、术前用药、美国麻醉医师协会(ASA)分级、手术时长和估计失血量(EBL)。两组之间的年龄、EBL、手术时长和ASA分级无显著差异。生理盐水IP组术后4小时(p = 0.02)和16小时(p = 0.04)的吗啡用量较高,8小时、12小时(p = 0.06)和24小时(p = 0.09)时也有用量增加的趋势。总体而言,生理盐水IP组(n = 10)使用(中位数;范围)21.5;8 - 82毫克吗啡,而DMG IP组(n = 10)使用10.5;1 - 23毫克。没有参与者报告术后感染。本研究表明,LAVH术中使用DMG溶液可使患者临床上疼痛感知减轻,随后吗啡用量往往减少约一半,有助于避免吗啡潜在的有害副作用和不良反应。